United States Biotechnology & Medical Research

Scribe Therapeutics Inc (SCTX)

Track

Track

Scribe Therapeutics witnessed significant insider buying activity recently, with multiple stakeholders acquiring shares. Despite a 14.7% decline in stock price over the last quarter, these purchases occurred following a positive earnings report. Total acquisitions reflect strong confidence from key entities and individuals, contrasting with the current market valuation near its fifty-two-week low.
Ticker: SCTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Scribe Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
160.04
Quantity 53,161 -26.6%
Value US$101,212
AH Bio Fund II, L.P. Large shareholder
Transaction date
Purchase
Price
157.34
Quantity 32,646 -31.0%
Value US$3,061,475
1.5
GORDON CARL L Non-Executive Director
Transaction date
Purchase
Price
463.36
Quantity 83,028 +28.2%
Value US$1,753,799
2.6
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 1,000,000 +286.7%
Value US$15,000,000
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
22.31
Quantity 50,000 +1.6%
Value US$1,115,500
Aghazadeh Behzad Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 2,333,333 +334.5%
Value US$34,999,995
2.1
Lucas Svetlana Chief Business Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 3,000 +inf%
Value US$45,000
Parrot David Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 1,333 +inf%
Value US$19,995
Parrot David Chief Financial Officer Officer
Transaction date
Purchase
Price
15.00
Quantity 1,333 +inf%
Value US$19,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-28 2026-07-28 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
53,161 -26.6%
160.04
US$101,212 		53,161 -26.6% 160.04 US$101,212
2026-07-29 2026-07-27 B Purchase
AH Bio Fund II, L.P.
Large shareholder
32,646 -31.0%
157.34
US$3,061,475 		32,646 -31.0% 157.34 US$3,061,475
2026-07-29 2026-07-27 B Purchase
1.5
GORDON CARL L
Non-Executive Director
83,028 +28.2%
463.36
US$1,753,799 		83,028 +28.2% 463.36 US$1,753,799
2026-07-29 2026-07-27 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
1,000,000 +286.7%
15.00
US$15,000,000 		1,000,000 +286.7% 15.00 US$15,000,000
2026-07-28 2026-07-24 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
50,000 +1.6%
22.31
US$1,115,500 		50,000 +1.6% 22.31 US$1,115,500
2026-07-28 2026-07-24 B Purchase
Aghazadeh Behzad
Non-Executive Director Large shareholder
2,333,333 +334.5%
15.00
US$34,999,995 		2,333,333 +334.5% 15.00 US$34,999,995
2026-07-27 2026-07-23 B Purchase
2.1
Lucas Svetlana

Chief Business Officer

Officer
3,000 +inf%
15.00
US$45,000 		3,000 +inf% 15.00 US$45,000
2026-07-27 2026-07-23 B Purchase
Parrot David

Chief Financial Officer

Officer
1,333 +inf%
15.00
US$19,995 		1,333 +inf% 15.00 US$19,995
2026-07-27 2026-07-23 B Purchase
Parrot David

Chief Financial Officer

Officer
1,333 +inf%
15.00
US$19,995 		1,333 +inf% 15.00 US$19,995
Explore more

More insider trading research around Scribe Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America